Influence of prior pregnancies on disease course and cause of death in systemic sclerosis
暂无分享,去创建一个
S. Jimenez | C. Artlett | H. Sawaya | M. Rasheed | K. Russo-Stieglitz | Sergio A Jimenez | Mehmoodur Rasheed
[1] M. Hebbar,et al. Relationship between parity and clinical and biological features in patients with systemic sclerosis. , 2001, The Journal of rheumatology.
[2] F. Miller,et al. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies , 2000, The Lancet.
[3] M. Piccinni,et al. Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy , 2000, Journal of Neuroimmunology.
[4] Takafumi Nakamura,et al. Changes in Cytokine Production During and After Normal Pregnancy , 2000, American journal of reproductive immunology.
[5] 島岡 有貴. Changes in cytokine production during and after normal pregnancy , 2000 .
[6] mith,et al. IDENTIFICATION OF FETAL DNA AND CELLS IN SKIN LESIONS FROM WOMEN WITH SYSTEMIC SCLEROSIS , 2000 .
[7] D. Furst,et al. Microchimerism of maternal origin persists into adult life. , 1999, The Journal of clinical investigation.
[8] S. Jimenez,et al. New perspectives on the etiology of systemic sclerosis. , 1999, Molecular medicine today.
[9] H. Schlebusch,et al. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. , 1998, Biochemical and biophysical research communications.
[10] D. Furst,et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma , 1998, The Lancet.
[11] V. Deneys,et al. Immunological tolerance of the fetal allograft: efficacy of immunotherapy and IL-4 and TNF alpha serum levels in recurrent abortion. , 1997, Transplantation proceedings.
[12] S. Jimenez,et al. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis , 1997, Immunogenetics.
[13] S. Jimenez,et al. Pathogenesis of scleroderma. Collagen. , 1996, Rheumatic diseases clinics of North America.
[14] E. Leroy. SYSTEMIC SCLEROSIS : A Vascular Perspective , 1996 .
[15] Y. Okano,et al. Antinuclear antibody in systemic sclerosis (scleroderma). , 1996, Rheumatic diseases clinics of North America.
[16] J. Nelson,et al. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? , 1996, Arthritis and rheumatism.
[17] G. Weil,et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Levine,et al. Cytokine dysregulation and the initiation of systemic autoimmunity. , 1994, Immunology letters.
[19] E. Leroy,et al. Cytokines and systemic sclerosis. , 1994, Clinics in dermatology.
[20] T. Mosmann,et al. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. , 1993, Journal of immunology.
[21] E. Smith. Connective tissue metabolism including cytokines in scleroderma , 1992, Current opinion in rheumatology.
[22] A. Silman. Pregnancy and Scleroderma , 1992, American journal of reproductive immunology.
[23] Y. Yagami,et al. Fetal cells in the maternal circulation: detection of Y-sequence by gene amplification. , 1992, Obstetrics and gynecology.
[24] R. Altman,et al. Introduction and overview: Pain in osteoarthritis , 1989 .
[25] M. Kahaleh,et al. Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration. , 1989, Annals of internal medicine.
[26] S. Jimenez,et al. Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients. , 1988, Seminars in arthritis and rheumatism.
[27] A. Silman,et al. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. , 1988, Annals of the rheumatic diseases.
[28] T. Medsger,et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.
[29] J. Saurat,et al. Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man. , 1984, The American journal of pathology.
[30] S. Jiménez. Cellular immune dysfunction and the pathogenesis of scleroderma. , 1983, Seminars in arthritis and rheumatism.
[31] G. Janossy,et al. LYMPHOID INFILTRATES IN SKIN IN GRAFT-VERSUS-HOST DISEASE , 1981, The Lancet.
[32] M. Gaillard,et al. Microchimerism in pregnant mice. , 1981, Transplantation proceedings.
[33] A. Masi. Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.
[34] W. Adler,et al. Maternal cell traffic in allogeneic embryos , 1980 .
[35] James F. Fries,et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.
[36] A. Gratwohl,et al. Scleroderma, Sjögren-like syndrome, and chronic graft-versus-host disease. , 1977, Annals of internal medicine.
[37] M. Siimes,et al. SCLERODERMA-LIKE GRAFT-VERSUS-HOST DISEASE AS LATE CONSEQUENCE OF BONE-MARROW GRAFTING , 1977, The Lancet.
[38] J. R. Reeves,et al. Cellular infiltrates in scleroderma skin. , 1977, Arthritis and rheumatism.
[39] R. Winkelmann. SCLERODERMA AND PREGNANCY. , 1965, Clinical obstetrics and gynecology.
[40] Winkelmann Rk,et al. SCLERODERMA AND PREGNANCY. , 1964 .